Published in:
Open Access
14-12-2023 | Propranolol | Journal club
Cavernomas: to treat or not to treat?
Authors:
Sophie Voase, Neil P. Robertson
Published in:
Journal of Neurology
|
Issue 1/2024
Login to get access
Excerpt
Cerebral cavernous malformations (CCMs), also referred to as cavernomas or cavernous angiomas, can occur sporadically or as an inherited trait. CCMs can be asymptomatic and incidental findings on brain imaging or symptomatic because of haemorrhage, seizures, or headaches. Haemorrhage risk for CCMs vary according to whether they are incidentally detected and unruptured or have previously bled. The re-haemorrhage rate for CCMs is between 4.5 and 22.9% annually if there has been a single haemorrhage event, or up to 33% if there have been multiple previous events. Currently, there is no consensus on acute or longer term management of CCMs. In this month’s journal club, we explore three recent studies investigating interventions to reduce future haemorrhage risk and that propose future management strategies for symptomatic CCMs. …